Clinical Trial Update: An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the imaging agent I-124 M5A for detecting CEA-positive liver metastases in colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Cancer with Liver Metastases

Drugs mentioned

• I-124 M5A

Snippet

Sponsor: City of Hope Medical Center | Conditions: Colorectal Carcinoma Metastatic in the Liver, Metastatic Colorectal Carcinoma | Phase 1 | Status: COMPLETED